SINT
SINTXBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
A new commercial leader, a newly cleared foot-and-ankle product, and a deliberate shift away from low-margin OEM work create a plausible path to a cleaner higher-margin medtech story if management can show early adoption and partnership progress [#8-K-2026-02-18] [#10-K-2026-03-20].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Commercial adoption of silicon-nitride implants may remain too limited to offset the planned reduction in OEM revenue.
Momentum
87
Value
36
Sentiment
43
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.20 · Bull $4.25 · Bear $1.00
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-22 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $12.25
Why
Momentum87 · Δ7d -
Value36 · Δ7d -0.0
Sentiment43 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
87
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
43
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 86.9 / Value 36.3 / Sentiment 43.2
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$8.98M
Beta
0.70
Shares Out
3.85M
P/E (TTM) · Derived
-0.2
P/S (TTM)
11.19
P/FCF (TTM) · Derived
-0.66
Rev YoY
-74.0%
EPS YoY
+50.3%
Gross Margin
+52.0%
Op Margin
-798.0%
Net Debt
-$3.57M
Current Ratio
1.70
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology